National Vision EYE has shown strong year-to-date momentum, with its shares rising 28.2%. This has far outpaced the industry’s 3.4% growth and the S&P 500 composite’s 2.2% fall. Currently carrying a ...

The rapid rise of GLP-1 weight-loss drugs has come with a raucous side show—a wave of copycat drugs unbound by drug patents. The knockoff surge was led by Hims & Hers Health, the telehealth firm ...

But with only about 12,000 dermatologists in the U.S., some patients may have trouble finding a provider. Telehealth ...

Hims & Hers Health (NYSE: HIMS) stock jumped 2.2% through 10:45 a.m. ET Monday after Morgan Stanley analyst Craig Hettenbach ...

In recent years, telehealth companies like Hims and Keeps have revolutionized access to hair loss treatments by offering online consultations and direct-to-door deliveries. Their nearly ubiquitous ...

But as the drugstore chain (WBA) prepares to go private and its rival CVS Health Inc. (CVS) experiments with smaller stores, some analysts and researchers see a possible future with even fewer ...

Mark Millich, 26 years old and insecure about his thinning hair, was curious about the ads he saw promising to reverse his hair loss. He completed a 14-question intake on Hims.com and received a ...

Since the first treatments hit the market more than 20 years ago, erectile dysfunction (ED) medications have become a multibillion-dollar industry. Many treatments are available, and with the ...

The Healthcare Information and Management Systems Society (HIMSS) got a surprise visit from Shark Tank host Daymond John during its annual conference in Las Vegas this year. John—who is the ...